|
Nifedipine Impurity D
|
硝苯地平杂质D
|
80012-11-9
|
|
Lercanidipine Impurity A
|
乐卡地平杂质A
|
74936-74-6
|
|
Amlodipine Impurity K
|
氨氯地平杂质K
|
1809326-44-0
|
|
Nicardipine Impurity 6
|
尼卡地平杂质6
|
101-98-4
|
|
Iopromide Impurity 8(Mixture of Diastereomers)
|
碘普胺杂质8（非对映异构体混合物）
|
|
|
Lurasidone Impurity 4Sodium Salt (Mixture of Diastereomers)
|
鲁拉西酮杂质4 钠盐（非对映异构体混合物）
|
|
|
Duloxetine Impurity19
|
度洛西汀杂质19
|
1384080-33-4
|
|
Duloxetine Impurity 16
|
度洛西汀杂质 16
|
1384080-56-1
|
|
Metronidazole Impurity1
|
甲硝唑杂质1
|
56750-04-0
|
|
Pomalidomide Impurity 26
|
泊马度胺杂质26
|
498-25-9
|
|
Pomalidomide Impurity 14
|
泊马度胺杂质14
|
1799711-25-3
|
|
Iopromide EP Impurity D (Mixture of Diastereomers)
|
碘普罗胺EP杂质D（非对映异构体混合物）
|
154361-55-4
|
|
Iopromide Impurity 5
|
碘普罗胺杂质5
|
57469-50-8
|
|
Duloxetine Impurity 14
|
度洛西汀杂质 14
|
178273-35-3
|
|
lurasidone impurity24
|
鲁拉西酮杂质24
|
27862-85-7
|
|
Pomalidomide Impurity 22
|
泊马度胺杂质22
|
2097971-16-7
|
|
Valsartan Impurity 12
|
缬沙坦杂质 12
|
2459446-44-5
|
|
lurasidone impurity21
|
鲁拉西酮杂质21
|
55745-83-0
|
|
Duloxetine EP Impurity C
|
度洛西汀杂质C
|
949095-98-1
|
|
rac-Valsartan EP Impurity B
|
rac-缬沙坦EP杂质B
|
1894176-44-3
|
|
Duloxetine Related Compound J
|
度洛西汀相关化合物 J
|
|
|
Valsartan Desvaleryl Impurity
|
缬沙坦脱缬氨酰杂质
|
676129-92-3
|
|
Lurasidone Impurity Sulfone
|
鲁拉西酮杂质砜
|
1644295-09-9
|
|
Metronidazole Impurity7
|
甲硝唑杂质7
|
110578-73-9
|
|
Metronidazole-O-Glucuronide
|
甲硝唑葡糖苷酸
|
100495-98-5
|
|
Valsartan Impurity 15
|
缬沙坦杂质15
|
1314799-75-1
|
|
Duloxetine EP Impurity D
|
度洛西汀EP杂质 D
|
90-15-3
|
|
Metronidazole EP Impurity C
|
甲硝唑EP杂质C
|
5006-69-9
|
|
Iopromide Impurity 17
|
碘普罗胺杂质17
|
103254-63-3
|
|
Duloxetine impurity (N-formyl)
|
度洛西汀杂质（N-甲酰基）
|
1243540-89-7
|
|
Valsartan Impurity 7
|
缬沙坦杂质 7
|
114772-54-2
|
|
lurasidone impurity31
|
鲁拉西酮杂质31
|
1318074-22-4
|
|
Valsartan Impurity 6
|
缬沙坦杂质 6
|
|
|
Duloxetine EP Impurity A
|
度洛西汀EP杂质 A
|
910138-96-4
|
|
Valsartan Impurity14(mixture of E/Z-isomers)
|
缬沙坦杂质14（E/Z-异构体的混合物）
|
149709-59-1
|
|
lurasidone impurity39
|
鲁拉西酮杂质39
|
1318074-20-2
|
|
lurasidone impurity19
|
鲁拉西酮杂质19
|
14805-29-9
|
|
Pomalidomide Impurity 28
|
泊马度胺杂质28
|
610-27-5
|
|
lurasidone impurity10
|
鲁拉西酮杂质10
|
1072-95-3
|
|
Valsartan Desvaleryl Methyl Ester
|
缬沙坦去缬氨酰甲酯
|
1111177-24-2
|
|
Pomalidomide Impurity 25
|
泊马度胺杂质25
|
6946-22-1
|
|
Duloxetine Impurity3
|
度洛西汀杂质3
|
132335-46-7
|
|
N-(2-Hydroxy-1-naphthyl)acetamide
|
N-(2- 羟基 -1- 萘基)乙酰胺
|
117-93-1
|
|
Valsartan N2-Trityl R-Isomer
|
缬沙坦 N2-三苯甲基 R-异构体
|
|
|
1-Methyl-4-nitroimidazole
|
1-甲基-4-硝基咪唑（甲硝唑杂质）
|
3034-41-1
|
|
Iopromide Impurity 14
|
碘普罗胺杂质14
|
132327-79-8
|
|
Valsartan Isopropyl Ester
|
缬沙坦异丙酯
|
|
|
Pomalidomide Impurity 7
|
泊马度胺杂质7
|
918314-45-1
|
|
Duloxetine impurity (N-acetyl)
|
度洛西汀杂质（N-乙酰）
|
1243540-90-0
|
|
Pomalidomide Impurity 8
|
泊马度胺杂质8
|
2635-64-5
|
|
4-Hydroxy Duloxetine
|
4-羟基度洛西汀
|
662149-13-5
|
|
lurasidone impurity5
|
鲁拉西酮杂质5
|
1807607-99-3
|
|
lurasidone impurity13
|
鲁拉西酮杂质13
|
1807983-61-4
|
|
Duloxetine Impurity2
|
度洛西汀杂质2
|
878757-08-5
|
|
Pomalidomide Impurity 20
|
泊马度胺杂质20
|
2093387-50-7
|
|
lurasidone impurity35
|
鲁拉西酮杂质35
|
15753-50-1
|
|
Pomalidomide Impurity 23
|
泊马度胺杂质23
|
1001852-10-3
|
|
Duloxetine related substance F
|
度洛西汀相关物质F
|
1104890-90-5
|
|
Iopromide Impurity 15
|
碘普罗胺杂质15
|
2094967-67-4
|
|
lurasidone impurity34
|
鲁拉西酮杂质34
|
1318074-27-9
|
|
Iopromide Impurity 3
|
碘普罗胺杂质3
|
76801-94-0
|
|
3-Dimethylamino-1-(2-thienyl)-1-propanol
|
3-二甲氨基-1-(2-噻吩基)-1-丙醇
|
13636-02-7
|
|
lurasidone impurity28
|
鲁拉西酮杂质28
|
173658-50-9
|
|
lurasidone impurity33
|
鲁拉西酮杂质33
|
1841093-19-3
|
|
Iopromide Impurity 4
|
碘普罗胺杂质4
|
111487-77-5
|
|
lurasidone impurity2
|
鲁拉西酮杂质2
|
316363-65-2
|
|
Valsartan Impurity 16
|
缬沙坦杂质16
|
2254485-68-0
|
|
Valsartan Impurity 2
|
缬沙坦杂质 2
|
2459446-36-5
|
|
MetronidazoleEPImpurityG
|
甲硝唑EP杂质G
|
1010-93-1
|
|
Pomalidomide Impurity 3
|
泊马度胺杂质3
|
328-48-3
|
|
lurasidone impurity3
|
鲁拉西酮杂质3
|
1260138-03-1
|
|
Metronidazole Impurity16
|
甲硝唑杂质16
|
73829-38-6
|
|
Valsartan Impurity 17
|
缬沙坦杂质17
|
1353844-77-5
|
|
Duloxetine N-Methyl Oxalate
|
度洛西汀N-草酸甲酯
|
132335-47-8
|
|
Valsartan Impurity 5
|
缬沙坦杂质 5
|
914465-68-2
|
|
Valsartan N1-Trityl R-Isomer
|
缬沙坦 N1-三苯甲基 R-异构体
|
|
|
Duloxetine Impurity 15 (alpha-Hydroxy)
|
度洛西汀杂质15（α-羟基）
|
940291-11-2
|
|
Duloxetine USP Related Compound H
|
度洛西汀USP相关化合物 H
|
199191-66-7
|
|
Pomalidomide Impurity 29
|
泊马度胺杂质29
|
5434-21-9
|
|
lurasidone impurity15
|
鲁拉西酮杂质15
|
1574569-32-6
|
|
Iopromide Impurity 7
|
碘普罗胺杂质7
|
874302-08-6
|
|
Metronidazole EP Impurity B (4-Nitroimidazole)
|
甲硝唑EP杂质B（4-硝基咪唑）
|
3034-38-6
|
|
lurasidone impurity17
|
鲁拉西酮杂质17
|
|
|
Duloxetine Impurity 20
|
度洛西汀杂质20
|
947686-09-1
|
|
Iopromide Impurity 10
|
碘普罗胺杂质10
|
1009809-15-7
|
|
Duloxetine Impurity 9
|
度洛西汀杂质9
|
116539-57-2
|
|
Duloxetine EP Impurity B
|
度洛西汀EP杂质 B
|
116539-55-0
|
|
Pomalidomide Impurity 27
|
泊马度胺杂质27
|
191732-76-0
|
|
Iopromide EP Impurity C (Mixture of Diastereomers)
|
碘普罗胺EP杂质C（非对映异构体混合物）
|
154361-52-1
|
|
lurasidone impurity12
|
鲁拉西酮杂质12
|
188797-79-7
|
|
lurasidone impurity36
|
鲁拉西酮杂质36
|
1365987-23-0
|
|
lurasidone impurity38
|
鲁拉西酮杂质38
|
139506-03-9
|
|
Iopromide Impurity 16
|
碘普罗胺杂质16
|
1821027-16-0
|
|
Pomalidomide Impurity 32
|
泊马度胺杂质32
|
918314-44-0
|
|
Pomalidomide Impurity 13
|
泊马度胺杂质13
|
2022182-58-5
|
|
Iopromide Impurity 13
|
碘普罗胺杂质13
|
2756222-41-8
|
|
(R)-Pomalidomide
|
(R)-泊马度胺
|
202271-90-7
|
|
Iopromide EP Impurity B
|
碘普胺EP杂质B
|
76350-28-2
|
|
Pomalidomide Impurity A
|
泊马度胺杂质A
|
641-70-3
|
|
lurasidone impurity7
|
鲁拉西酮杂质7
|
4430-91-5
|